KR20040004406A - 개의 통증 및 염증을 치료하기 위한사이클로-옥시게나제-2 선택적 억제 화합물 - Google Patents
개의 통증 및 염증을 치료하기 위한사이클로-옥시게나제-2 선택적 억제 화합물 Download PDFInfo
- Publication number
- KR20040004406A KR20040004406A KR10-2003-7005258A KR20037005258A KR20040004406A KR 20040004406 A KR20040004406 A KR 20040004406A KR 20037005258 A KR20037005258 A KR 20037005258A KR 20040004406 A KR20040004406 A KR 20040004406A
- Authority
- KR
- South Korea
- Prior art keywords
- cox
- carpropene
- inhibitor
- inflammatory
- dogs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4563597P | 1997-05-05 | 1997-05-05 | |
| US60/045,635 | 1997-05-05 | ||
| PCT/IB1998/000662 WO1998050033A1 (en) | 1997-05-05 | 1998-05-01 | Cox-2 selective carprofen for treating pain and inflammation in dogs |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019997010252A Division KR20010012300A (ko) | 1997-05-05 | 1998-05-01 | 개의 통증 및 염증을 치료하기 위한 콕스-2 선택적카르프로펜 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20040004406A true KR20040004406A (ko) | 2004-01-13 |
Family
ID=21939053
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019997010252A KR20010012300A (ko) | 1997-05-05 | 1998-05-01 | 개의 통증 및 염증을 치료하기 위한 콕스-2 선택적카르프로펜 |
| KR10-2003-7005258A KR20040004406A (ko) | 1997-05-05 | 1998-05-01 | 개의 통증 및 염증을 치료하기 위한사이클로-옥시게나제-2 선택적 억제 화합물 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019997010252A KR20010012300A (ko) | 1997-05-05 | 1998-05-01 | 개의 통증 및 염증을 치료하기 위한 콕스-2 선택적카르프로펜 |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP0988034A1 (es) |
| JP (1) | JP2000513020A (es) |
| KR (2) | KR20010012300A (es) |
| CN (1) | CN1255059A (es) |
| AP (1) | AP9801234A0 (es) |
| AR (2) | AR011726A1 (es) |
| AU (1) | AU6932198A (es) |
| BG (1) | BG103852A (es) |
| BR (1) | BR9808720A (es) |
| CA (1) | CA2288759A1 (es) |
| DZ (1) | DZ2479A1 (es) |
| EA (1) | EA003696B1 (es) |
| GT (1) | GT199800063A (es) |
| HR (1) | HRP980244A2 (es) |
| HU (1) | HUP0001286A3 (es) |
| ID (1) | ID21311A (es) |
| IL (1) | IL132570A0 (es) |
| IS (1) | IS5220A (es) |
| MA (1) | MA26491A1 (es) |
| NO (1) | NO995389L (es) |
| NZ (1) | NZ500183A (es) |
| OA (1) | OA11213A (es) |
| PA (1) | PA8450601A1 (es) |
| PE (1) | PE72599A1 (es) |
| PL (1) | PL337003A1 (es) |
| SK (1) | SK148199A3 (es) |
| TN (1) | TNSN98059A1 (es) |
| TW (1) | TW590773B (es) |
| UY (1) | UY24989A1 (es) |
| WO (1) | WO1998050033A1 (es) |
| YU (1) | YU55899A (es) |
| ZA (1) | ZA983722B (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6245797B1 (en) | 1997-10-22 | 2001-06-12 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease |
| AU2003204888B2 (en) * | 1998-05-22 | 2005-07-28 | Pfizer Products Inc. | Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives |
| US6506785B2 (en) * | 1998-05-22 | 2003-01-14 | Pfizer, Inc. | Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives |
| EP1123091A1 (en) * | 1998-10-23 | 2001-08-16 | Merck Frosst Canada & Co. | Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| EP1637137A3 (en) * | 1999-03-10 | 2006-07-05 | G.D. Searle LLC | Method and composition for administering a cyclooxygenase-2 inhibitor to animals |
| AU1592901A (en) * | 1999-11-11 | 2001-06-06 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| AU2001259974A1 (en) * | 2000-05-15 | 2001-11-26 | Merck Frosst Canada & Co | Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| EA200802070A1 (ru) | 2000-06-13 | 2009-06-30 | Вайет | Болеутоляющее и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2 |
| DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
| WO2002012549A1 (en) | 2000-08-07 | 2002-02-14 | Vanderbilt University | Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites |
| AU2002354901A1 (en) * | 2001-07-16 | 2003-03-03 | Edward Hogestatt | Compounds with analgesic, antipyretic and/or anti-inflammatory activity |
| ATE342722T1 (de) | 2003-05-07 | 2006-11-15 | Osteologix As | Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen |
| KR100780983B1 (ko) * | 2003-07-31 | 2007-11-30 | 파마시아 앤드 업존 캄파니 엘엘씨 | 소염제의 분산성 제제 |
| EP1940380A2 (en) * | 2005-05-20 | 2008-07-09 | Pfizer Limited | Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-2 delta-ligands |
| US9114071B2 (en) | 2007-04-04 | 2015-08-25 | Sigmoid Pharma Limited | Oral pharmaceutical composition |
| JP2010527285A (ja) | 2007-04-26 | 2010-08-12 | シグモイド・ファーマ・リミテッド | 複数のミニカプセルの製造 |
| ES2649112T3 (es) | 2009-05-18 | 2018-01-10 | Sigmoid Pharma Limited | Composición que comprende gotas de aceite |
| WO2011018504A2 (en) | 2009-08-12 | 2011-02-17 | Sigmoid Pharma Limited | Immunomodulatory compositions comprising a polymer matrix and an oil phase |
| GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
| GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
| GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| WO2015134792A1 (en) | 2014-03-06 | 2015-09-11 | Aratana Therapeutics, Inc. | Compositions of grapiprant and methods for using the same |
| BR112017009510A2 (pt) | 2014-11-07 | 2017-12-19 | Sigmoid Pharma Ltd | composições compreendendo ciclosporina |
| CN107106536A (zh) * | 2015-01-09 | 2017-08-29 | 美洲豹动物健康公司 | 治疗伴侣动物的腹泻的方法 |
| US20230174485A1 (en) * | 2020-03-25 | 2023-06-08 | Sri International | Lipoxygenase inhibitors |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
| KR102404883B1 (ko) | 2020-11-30 | 2022-06-07 | (주)이노보테라퓨틱스 | 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3896145A (en) * | 1972-07-24 | 1975-07-22 | Hoffmann La Roche | Carbazoles |
| CA1319886C (en) * | 1987-02-03 | 1993-07-06 | Alberto Ferro | Mixed micelle solutions |
-
1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/xx active
- 1998-04-30 TW TW087106689A patent/TW590773B/zh not_active IP Right Cessation
- 1998-05-01 CA CA002288759A patent/CA2288759A1/en not_active Abandoned
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 PL PL98337003A patent/PL337003A1/xx unknown
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/en not_active Application Discontinuation
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/hu unknown
- 1998-05-01 IL IL13257098A patent/IL132570A0/xx unknown
- 1998-05-01 EP EP98915041A patent/EP0988034A1/en not_active Withdrawn
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/ko not_active Application Discontinuation
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/pt not_active IP Right Cessation
- 1998-05-01 JP JP10547869A patent/JP2000513020A/ja active Pending
- 1998-05-01 CN CN98804845A patent/CN1255059A/zh active Pending
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/ko not_active Application Discontinuation
- 1998-05-01 ID IDP980651A patent/ID21311A/id unknown
- 1998-05-01 EA EA199900895A patent/EA003696B1/ru not_active IP Right Cessation
- 1998-05-01 SK SK1481-99A patent/SK148199A3/sk unknown
- 1998-05-01 YU YU55899A patent/YU55899A/sh unknown
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/fr unknown
- 1998-05-04 PE PE1998000335A patent/PE72599A1/es not_active Application Discontinuation
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/xx unknown
- 1998-05-04 MA MA25059A patent/MA26491A1/fr unknown
- 1998-05-04 UY UY24989A patent/UY24989A1/es not_active Application Discontinuation
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/es unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/hr not_active Application Discontinuation
- 1998-05-05 AR ARP980102089A patent/AR011726A1/es unknown
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/es unknown
-
1999
- 1999-10-19 IS IS5220A patent/IS5220A/is unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/xx unknown
- 1999-11-04 NO NO995389A patent/NO995389L/no not_active Application Discontinuation
-
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20040004406A (ko) | 개의 통증 및 염증을 치료하기 위한사이클로-옥시게나제-2 선택적 억제 화합물 | |
| US20060217431A1 (en) | Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a COX-2 inhibitor | |
| AU2015314772B2 (en) | Compositions and methods for treatment of prostate carcinoma | |
| JP2002526408A (ja) | 疼痛および不安の処置のためのｍｇｌｕｒ５アンタゴニスト | |
| KR20220140027A (ko) | 신경교종을 포함하는 암을 치료하기 위해 에플로르니틴 및 이의 유도체 및 동족체를 사용하기 위한 조성물 및 방법 | |
| EP2776031A1 (en) | N-methyl-2-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl]-benzamide for the treatment of chronic myelogenous leukemia | |
| EP1259234A1 (en) | 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy | |
| US20030212123A1 (en) | COX-2 selective carprofen for treating pain and inflammation in dogs | |
| JP2001514655A (ja) | アルツハイマー病予防へのｒ−ｎｓａｉｄ’ｓの利用 | |
| TW200817401A (en) | KW-3902 conjugates that do not cross the blood-brain barrier | |
| US20040266834A1 (en) | Thiazolidinediones alone or in cabination with other therapeutic agents for cancer therapy | |
| Quintás-Cardama et al. | Practical management of toxicities associated with tyrosine kinase inhibitors in chronic myeloid leukemia | |
| JP2000086629A (ja) | 新規な酸化窒素放出化合物 | |
| AU773615B2 (en) | COX-2 selective carprofen for treating pain and inflammation in dogs | |
| Black | Selective cyclooxygenase-2 inhibitors | |
| CZ9903896A3 (cs) | Léčivo, farmaceutický přípravek a souprava pro léčení nebo prevenci bolesti a zánětlivých procesů | |
| US20150065486A1 (en) | Methods for treating polycystic kidney disease | |
| NZ516914A (en) | Compositions containing COX-2 selective carprofen and derivatives thereof for treating pain and inflammation in dogs | |
| JP2016504994A (ja) | 糖尿病患者における心血管リスクの治療 | |
| JP2005525999A (ja) | 原発性脳腫瘍または転移性脳腫瘍を治療または予防するためのベンゾピラノン誘導体の使用 | |
| JP2007504164A (ja) | ＰＰＡＲ−γ経路およびＨＥＲ−キナーゼ軸の調節に基づく癌および他の生理学的状態の処置のための組成物および方法 | |
| US9962378B2 (en) | ROS1 inhibitor and its use | |
| FR2565588A1 (fr) | Produits pharmaceutiques cardio-actifs, en particulier anti-arythmiques, a base de composes triaminoarylpteridiniques | |
| US8933037B2 (en) | Methods involving PDGFRBETA inhibitors | |
| JPH09165338A (ja) | 梗塞サイズ減少剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A107 | Divisional application of patent | ||
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E601 | Decision to refuse application |